| Introduction to metallic nanoparticles VV Mody, R Siwale, A Singh, HR Mody Journal of Pharmacy and bioallied sciences 2 (4), 282-289, 2010 | 1272 | 2010 |
| Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge SW Hung, HR Mody, R Govindarajan Cancer letters 320 (2), 138-149, 2012 | 107 | 2012 |
| Model‐based cellular kinetic analysis of chimeric antigen receptor‐T cells in humans C Liu, VS Ayyar, X Zheng, W Chen, S Zheng, H Mody, W Wang, D Heald, ... Clinical Pharmacology & Therapeutics 109 (3), 716-727, 2021 | 66 | 2021 |
| PNIPAM Poly (N-isopropylacrylamide): A thermoresponsive “smart” polymer in novel drug delivery systems RR Kokardekar, VK Shah, HR Mody Internet Journal of Medical Update-EJOURNAL 7 (2), 2012 | 57 | 2012 |
| miR-202 diminishes TGFβ receptors and attenuates TGFβ1-induced EMT in pancreatic cancer HR Mody, SW Hung, RK Pathak, J Griffin, Z Cruz-Monserrate, ... Molecular Cancer Research 15 (8), 1029-1039, 2017 | 48 | 2017 |
| Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach SW Hung, S Marrache, S Cummins, YD Bhutia, H Mody, SB Hooks, ... Cancer letters 359 (2), 233-240, 2015 | 39 | 2015 |
| Inhibition of S-adenosylmethionine-dependent methyltransferase attenuates TGFβ1-induced EMT and metastasis in pancreatic cancer: putative roles of miR-663a and miR-4787-5p HR Mody, SW Hung, M AlSaggar, J Griffin, R Govindarajan Molecular Cancer Research 14 (11), 1124-1135, 2016 | 38 | 2016 |
| ANTIBACTERIAL ACTIVITY OF Cyanodon Dactylon ON DIFFERENT BACTERIAL PATHOGENS ISOLATED FROM CLINICAL SAMPLES Y Chaudhari, HR Mody, VB Acharya International Journal of Pharmaceutical Studies and Research 1, 16-20, 2011 | 38 | 2011 |
| Bench to Bedside Translation of Chimeric Antigen Receptor (CAR) T Cells Using a Multiscale Systems PK‐PD Model: A Case Study with Anti‐BCMA CAR‐T AP Singh, W Chen, X Zheng, H Mody, TJ Carpenter, A Zong, DL Heald CPT: Pharmacometrics & Systems Pharmacology, 2021 | 30* | 2021 |
| A Review on Drug‐Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches H Mody, V Ramakrishnan, M Chaar, J Lezeau, A Rump, K Taha, L Lesko, ... Clinical Pharmacology in Drug Development, 2020 | 28 | 2020 |
| Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studies SW Hung, H Mody, S Marrache, YD Bhutia, F Davis, JH Cho, J Zastre, ... PloS one 8 (8), e71196, 2013 | 28 | 2013 |
| SET contributes to the epithelial-mesenchymal transition of pancreatic cancer HR Mody, SW Hung, K Naidu, H Lee, CA Gilbert, TT Hoang, RK Pathak, ... Oncotarget 8 (40), 67966, 2017 | 25 | 2017 |
| An Evaluation of Antibacterial Activity of Abelmoschus esculentus on Clinically Isolated Infectious Disease Causing Bacterial Pathogen from Hospital Y Chaudhari, EP Kumar, M Badhe, HR Mody, VB Acharya International Journal of Pharmaceutical and Phytopharmacological Research 1 …, 2011 | 21 | 2011 |
| Cancer nanotechnology: recent trends and developments HR Mody Internet Journal of Medical Update-EJOURNAL 6 (1), 2011 | 21 | 2011 |
| Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy–apoptosis crosstalk pathway B Fleisher, H Mody, C Werkman, S Ait-Oudhia Breast Cancer: Targets and Therapy, 231-241, 2019 | 17 | 2019 |
| In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization H Mody, TR Vaidya, S Ait-Oudhia Scientific Reports 13 (1), 3100, 2023 | 11 | 2023 |
| Poly (N-isopropylacrylamide) based polymer nanogels for drug delivery applications D Subhash, H Mody, R Banerjee, D Bahadur, R Srivastava 2011 11th IEEE International Conference on Nanotechnology, 1741-1744, 2011 | 11 | 2011 |
| An Investigation of Antibacterial Activity of Pedilanthus tithymaloides on Different Strains of Bacteria Y Chaudhari, M Badhe, EP Kumar, H Mody, R Kokardekar International Journal of Pharmaceutical and Phytopharmacological Research 1 …, 2012 | 7 | 2012 |
| Best practices and considerations for clinical pharmacology and pharmacometric aspects for optimal development of CAR‐T and TCR‐T cell therapies: an industry perspective H Mody, K Ogasawara, X Zhu, D Miles, PN Shastri, J Gokemeijer, MZ Liao, ... Clinical Pharmacology & Therapeutics 114 (3), 530-557, 2023 | 5 | 2023 |
| Multiscale and translational quantitative systems toxicology, pharmacokinetic-toxicodynamic modeling analysis for assessment of doxorubicin-induced cardiotoxicity TR Vaidya, H Mody, YL Franco, A Brown, S Ait-Oudhia The AAPS Journal 23, 1-16, 2021 | 4 | 2021 |
Yogesh ChaudhariDr. L. H. Hiranandani College of Pharmacy, UlhasnagarVerified email at dlhhcop.org
